NSAIDS and the gastrointestinal tract

Abdominal Imaging

Volumn 22, Issue 1, 1997, Pages 1-4

  Lanza, F L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT;

COLON ULCER; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HUMAN; INTESTINE ULCER; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; ULCER; ULCER HEALING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL DISEASES; HUMANS;

EID: 0031033032     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900127     Document Type: Review

References (33)

1. Cryer B, Feldman M. Effects of nonsteroidal antiinflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal antiinflammatory drug-induced damage. Arch Int Med 1992;152:1145-1155
2. Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987;82:1153-1158
3. Bellary SV, Isaacs PET, Lee FI. Upper gastrointestinal lesions in elderly patients presenting for endoscopy; relevance of NSAID usage. Am J Gastroenterol 1991;86:961-964
4. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-796
5. Bjarnason I, Hayllar J, Macpherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-1847
6. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-263
7. Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use in peptic ulcer disease; role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991;114:735-740
8. Sharr RJ, Ray WA, Daugherty JR, et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993;153:1665-1670
9. Naschitz JE, Yeshurun B, Odeh M, et al. Overt gastrointestinal bleeding: the course of chronic low dose aspirin administration for secondary prevention of arterial occlusive disease. Am J Gastroenterol 1990;85:408-411
10. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:769-772
11. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:1075-1078
12. Lanza FL. Gastrointestinal toxicity of newer NSAIDs. AMJ Gastroenterol 1993;88:1318-1323
13. Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979;91:517-520
14. Quigley EMM, Donovan JP, Livingston WC. Ketorolac related giant gastric ulcers. AMJ Gastroenterol 1994;89:631-632
15. McCarthy DM. Sucralfate. N Engl J Med 1991;325:1017-1025
16. French PC, Darekar B, Mills JG, et al. Meta-analysis of studies with ranitidine in the prevention of NSAID-associated ulcers. Gastroenterology 1993;104 (S):A81
17. Graham DY, Agrawal MN, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988;ii:1277-1280
18. Agrawal NM, Roth SH, Graham DY, et al. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer in randomized control trial. Ann Intern Med 1991;115:195-200
19. White R, Raskin JB, Sue SO. Efficacy and safety of misoprostol in the prevention of NSAID-induced duodenal ulcer. Preliminary findings. Gastroenterology 1993;104 (S):A223
20. Raskin JB, White R, Sue SO. Efficacy and safety of misoprostol in the prevention of NSAID-induced gastric ulcer. Preliminary findings. Gastroenterology 1993;104 (S):A177
21. Graham DY, White RH, Moreland W, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993;119 (4):257-262
22. Silverstein FE, Geis GS, Struthers BJ. NSAIDs and gastrointestinal injury: clinical outcome, the mucosa trial. Gastroenterology 1994;106:A180
23. McCarthy DM. Nonsteroidal anti-inflammatory drug-induced ulcers: management by traditional therapy. Gastroenterology 1989;96 (suppl):662-674
24. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of nonsteroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991;32:69-75
25. Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:59-75
26. Laine L, Marin-Sorenson M, Weinsein WM. Nonsteroidal anti-inflammatory drug associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992;87:1398-1402
27. Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforation and hemorrhage. Br Med J 1985;290:347-349
28. Madhok R, Mackenzie JA, Lee FD, et al. Small bowel ulceration in patients receiving NSAIDs for rheumatoid arthritis. Q J Med 1986;58:53-58
29. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992;327:749-754
30. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Arch Intern Med 1992;152:625-632
31. Tanaka M, Mazzoleni G, Ridell RH. Nonsteroidal anti-inflammatory drugs as a possible cause of collagenous colitis [Abstract]. Gastroenterology 1991;101:A845
32. Wilson RG, Smith AN, Macintyre IMC. Complications of diverticular disease and non-steroidal anti-inflammatory drugs. A prospective study. Br J Surg 1990;77:1103-1104
33. Kaufman HJ, Taubin HL. NSAIDs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-516